Search PubMed⌕ Search

Biomedical subjects

G Sakellaropoulos

Publications and source records attributed to G Sakellaropoulos.

22 records · Page 2Linked to original sources

Intracellular Ca2+ signaling induced by osmotic shock in human T lymphocytes.

After exposure to hypo-osmotic medium most vertebrate cells are able to reregulate their volume by losing electrolytes (K, Cl) and water, a process called regulatory volume decrease (RVD). The whole process of RVD requires a sensor(s) to detect swelling, a transducer(s) to translate the signal, and effectors that cause electrolyte loss. In many cell types an increase in cytoplasmic calcium (Cai) is the transducer and T lymphocytes were formerly thought to fit this pattern. However, this model was thrown into doubt by experiments on Cai-depleted T cells and by the previous failure to detect Cai changes. In the present study we used Ca fluorescence measurements of fluo-3-loaded normal human T lymphocytes exposed to 60% hypo-osmotic saline in a perfused cuvette. We show that hypo-osmotic shock causes a rapid rise in Cai (averaged over approximately 10(4) cells) due to both release of Ca from internal stores and influx. Ca2+ influx occurred at room temperature as well as at 37 degrees C and at a variety of external Ca2+ concentrations (1, 1.5, 2.5 mM). Following hypo-osmotic shock, reexposure to normal osmolarity restored Cai to resting levels. Cell viability and biological responsiveness were not impaired by these osmotic treatments and the subsequent biphasic Cai rise in response to a mitogenic lectin was normal. Using the whole-cell, patch-clamp technique we have isolated an inward cation current that can be carried by Ca2+. Both this current and the Cai rise were blocked by micromolar gadolinium; hence, this current may provide the Ca2+ influx pathway during a hypo-osmotic shock. Finally, these results and recent information on K, Cl, and cation channels in human T cells are incorporated into a model for RVD in these cells.

Aniline Compounds↗

Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.

Gonadotropin-releasing hormone analogues (GnRH-a) are currently used in combination with gonadotropins in ovarian stimulation for in vitro fertilization programs (IVF). The present study aims at evaluating the treatment cycles for IVF for which human menopausal gonadotropin (HMG) was initiated only when pituitary desensitization was confirmed regardless of the time of GnRH-a administration. Two groups of patients were examined. Patients in group A (n = 46) were commenced with HMG treatment on day 15 when E2 level was less than 40 pg/ml. Group B patients (n = 27) comprised the cycle treatments in which E2 levels were greater than 40 pg/ml on day 15. In these cases HMG was first given when E2 levels declined to less than 40 pg/ml. The fertilization rate was similar in both A and B groups, 71.6 and 67.7% respectively. The pregnancy rate per transfer was 27.5 and 34.6% in group A and B respectively. Multiple pregnancies were found at 18.1% in group A versus 44.4% in group B. It is concluded that postponement of HMG administration in patients with high levels of E2 on day 15 after GnRH-a administration seems to offer an improvement in embryo cleavage speed, pregnancy rate and multiple pregnancies.

Adult↗

Psychosomatic symptoms of postmenopausal women with or without hormonal treatment.

The purpose of this study is to compare the psychosomatic symptoms of postmenopausal women who are users of hormonal treatment with the psychosomatic symptoms of nonusers. We studied 68 postmenopausal women receiving estrogen treatment (age range 48-56 years; 51.1 +/- 1.9, mean +/- SD) and 50 postmenopausal women (age range 45-55 years; 50.7 +/- 2.5) as controls. The symptoms we studied were: (1) nightly perspiration; (2) vasomotor flushes; (3) dyspnea; (4) vertigo; (5) headache; (6) disturbance of libido; (7) depression, and (8) anxiety. We found a beneficial effect of estrogen treatment in nightly perspiration (p less than 0.01), vasomotor flushes (p less than 0.001) and disturbance of libido (p less than 0.01). We found no difference between the two groups in dyspnea, vertigo, headache, depression and anxiety. Our findings show that with hormonal treatment in postmenopausal women there is a beneficial effect in only some psychosomatic symptoms.

Climacteric↗

Assessment of angiogenesis in human cervical lesions.

Angiogenesis has been extensively studied in several types of invasive carcinomas and has been correlated-with tumor growth and metastasis. In some of these studies it has been shown that angiogenesis preceeds neoplastic transformation. A correlation is evident between microvessel density and conditions that exist much before the onset of tumor formation (i.e. dysplastic lesions). In this study, tumor vascularity was quantified in a series of cervical lesions: 92 dysplasias (31 mild, 24 moderate and 36 severe) and 11 infiltrating squamous cell carcinomas. Microvessels were visualized by a polyclonal antibody against factor VIII-related antigen (DAKO), using a streptavidin-peroxidase immunohistochemical method. Vessel density was quantified in 3 high power fields (hpf) of the most vascular areas, by two independent observers. Mean vascular counts were 13 +/- 5 vessels per unit area in CIN I lesions, 17 +/- 4 in CIN II, 20 +/- 6 vessels in CIN III and 17 +/- 5 in infiltrating carcinomas. There was a progressive increase of vascularity in the dysplastic lesion in the samples with increasing atypia in relation to controls. No significant differences were noted between severe cervical dysplasias and infiltrating carcinomas. Our findings suggest that angiogenesis may be an important event in tumor initiation and the conversion of the normal epithelium into cancer.

Carcinoma in Situ↗